Investor Tips New vaccine entrant gets approval before Novavax, while herd immunity ideas put sales in doubt. Articles You May Like Stocks making the biggest moves midday: Nvidia, Monolithic Power Systems, Ralph Lauren and more What parents need to know about P2P payment apps as Venmo adds teen account Paramount pops after Buffett’s favorite banker makes ‘interesting’ bet in media giant’s key shareholder Gap shares soar after retailer reports big improvement in margins Here’s the ‘most likely scenario’ for when student loan payments could restart — and how to prepare